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Abstract 
Organ ischemia reperfusion injury (IRI), associated with acute hepatocyte death, remains an unresolved 
problem in clinical orthotopic liver transplantation (OLT). Autophagy, an intracellular self-digesting 
progress, is responsible for cell reprograming required to regain post-stress homeostasis. 
Methods: Here, we analyzed the cytoprotective mechanism of pituitary adenylate cyclase-activating 
polypeptide (PACAP)-promoted hepatocellular autophagy in a clinically relevant mouse model of 
extended hepatic cold storage (4 °C UW solution for 20 h) followed by syngeneic OLT. 
Results: In contrast to 41.7% of liver graft failure by day 7 post-transplant in control group, PACAP 
treatment significantly improved graft survival (91.7% by day 14), and promoted autophagy-associated 
regeneration programs in OLT. In parallel in vitro studies, PACAP-enhanced autophagy ameliorated 
cellular damage (LDH/ALT levels), and diminished necrosis in H2O2-stressed primary hepatocytes. 
Interestingly, PACAP not only induced nuclear cAMP response element-binding protein (CREB), but also 
triggered reprogramming factor Kruppel-like factor 4 (KLF4) expression in IR-stressed OLT. Indeed, 
CREB inhibition attenuated hepatic autophagy and recreated hepatocellular injury in otherwise 
PACAP-protected livers. Furthermore, CREB inhibition suppressed PACAP-induced KLF4 expression, 
whereas KLF4 blockade abolished PACAP-promoted autophagy and neutralized PACAP-mediated 
hepatoprotection both in vivo and in vitro. 
Conclusion: Current study documents the essential neural regulation of PACAP-promoted autophagy 
in hepatocellular homeostasis in OLT, which provides the emerging therapeutic principle to combat 
hepatic IRI in OLT. 
Key words: Liver Ischemia Reperfusion Injury, Orthotopic Liver Transplantation, PACAP, KLF4; CREB 
Introduction 
Liver ischemia reperfusion injury (IRI), an innate 
immunity-mediated sterile inflammation, represents a 
major complication in liver transplantation, 
hemorrhagic shock and partial hepatectomy [1]. It 
may lead to primary graft dysfunction and acute 
rejection episodes, which further deteriorate the organ 
shortage [1]. Liver IRI disturbs local blood circulation, 
generates reactive oxygen species (ROS), assembles 
peripheral neutrophils/macrophages, and inflicts 
tissue damage resulting in ultimate organ failure. Our 
group was the first to demonstrate that neuropeptide 
PACAP, which innervates the hepatic cells, 
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suppressed liver innate immune activation in a mouse 
model of liver warm ischemia followed by 
reperfusion [2,3]. The current study examined 
whether and how PACAP promoted hepatocellular 
autophagy to restore hepatocellular homeostasis in a 
clinically authentic model of hepatic cold IRI-OLT. 
Autophagy, an intracellular self-digesting 
progress degrading damaged organelles and 
malformed proteins by lysosomes, provides essential 
supply (amino acids, lipids and free fatty acid) to 
starved cells for energy metabolism and biosynthesis 
[4]. As various cargo transports to the lysosome, three 
autophagy forms have been identified, i.e., 
macroautophagy, microautophagy, and chaperone- 
mediated autophagy. Macroautophagy, the main 
autophagic pathway, could be divided into six 
principle steps to form the autophagosome: initiation, 
nucleation, elongation, closure, maturation and 
degradation or extrusion [5,6]. Fusing with lysosome, 
the autophagosome turns to autolysosome, in which 
the enclosed cytoplasmic materials are eventually 
degraded into active monomers [5,6]. As liver is rich 
in lysosome, dysregulation of macroautophagy 
(hereafter referred to as autophagy) is associated with 
multiple hepatic diseases, i.e., IRI, non-alcoholic 
steatohepatitis and liver cancer [7-9]. In liver 
transplantation, both warm and cold ischemia insults 
mainly interrupt the blood flow/oxygen supply, 
deplete hepatocellular adenosine triphosphate and 
produce ROS. This hepatocellular starvation 
significantly triggers autophagy signaling, which 
subsequently provides reused monomers to maintain 
cellular homeostasis [5,6,7,10]. 
Although liver IRI is considered as a local sterile 
innate response, both immune and nervous systems 
are integrated to maintain dynamic communication. 
IR-triggered inflammation was shown to activate 
systemic neuroendocrine hypothalamus and regional 
neural-hormonal–stress responses [11-13]. Neural 
regulation optimizes, monitors and adjusts immune 
response, as a pivotal feedback loop by stimulation of 
efferent vagus nerve activity [11,12]. After elimination 
of invasion, the neural system modulates local 
immune response towards host homeostasis [13]. 
PACAP, encoded by the ADCYAP1 gene, is a 
member of vasoactive intestinal peptide (VIP)/ 
glucagon/secretin family [14]. PACAP, contains two 
bioactive forms as 27 or 38 amino acid residues, 
functions as a neurotransmitter and neuromodulator 
in hypophysiotropic area, and involves in paracrine 
and autocrine regulation of gonadotrophs [15,16]. 
Consistent with others’ finding that PACAP exhibits 
neuroregulation on innate immunity [17], we have 
reported that partial warm IR triggered the inductions 
of hepatic PACAP and all three receptors in 
IR-stressed liver, whereas PACAP deficiency 
sensitized liver against IR-stress. Indeed, exogenous 
PACAP neuropeptide regulated the local innate 
immunity by diminishing neutrophil/macrophage 
sequestration in IR-liver and differentially 
modulating pro-inflammatory programs [2]. 
CREB, binding to cAMP response elements, is a 
critical cellular transcription factor in neuroregulation 
and neuron survival [18-20]. In innate immunity, 
CREB ameliorates TLR4 response by regulating 
macrophage polarization in infection and insulin 
resistance [21,22]. Recently, CREB was identified as an 
important regulator in hepatic autophagy gene 
network, promoting autophagic degradation of lipids 
[23]. We have recently shown that PACAP inhibited 
macrophage NF-κB activity by enhancing cAMP-PKA 
axis and CREB activity [2,3]. 
KLF4, the crucial self-renewal transcriptional 
factor of KLF family, exerts diverse modulation in 
proliferation, differentiation, and somatic cell 
reprogramming [24]. In addition to its crucial function 
in pluripotent stem cell induction [25,26], KLF4 is 
over-expressed in DNA-damaged non-dividing cells, 
and significant in inducing cell cycle arrest/ 
preventing cell division [27,28]. Indeed, KLF4 
regulates macrophage polarization by cooperating 
with Stat6 to induce M2 gene profile and sequestering 
NF-κB activators to suppress M1 phenotype [29]. 
Conversely, KLF4 extends the lifespan in nematode 
and modulates aged vascular dysfunction in mice by 
promoting autophagy [30]. Putative synergy between 
KLF4 and CREB in modulation of innate immunity 
was discovered in mycobacterium tuberculosis [21]. 
This study elucidated the cytoprotective role of 
PACAP-mediated autophagy in a clinically authentic 
mouse model of extended hepatic cold storage and 
followed syngeneic OLT. First, we determined 
whether and how PACAP neuropeptide protected 
liver grafts against extended cold storage in an 
autophagy-dependent manner. The question then 
arose whether PACAP-mediated autophagy could 
preserve hepatocyte viability, and promote hepatic 
regeneration/repair. Finally, we addressed whether 
PACAP-mediated CREB and KLF4 coactivation was 
essential for hepatic autophagy in liver IRI. 
Materials and Methods 
Liver extended cold storage followed by 
syngeneic OLT model 
Liver grafts from C57BL/6 mice were stored in 
4°C UW solution for 20 h, and then transplanted 
orthotopically into syngeneic C57BL/6 mice (male, 
8-12 weeks old, Jax lab, Bar Harbor, ME) [31-34]. 
Surgical details: after the recipient liver was removed, 
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donor suprahepatic vena cava was anastomosed end 
to end with recipient suprahepatic vena cava; both 
portal vein and infrahepatic vena cava were 
reconnected through a cuff technique; and bile duct 
reconstruction was completed with an intraluminal 
stent. Groups of recipients were given PBS, PACAP38 
(1 mg/kg via portal vein, dissolved in PBS, Phoenix 
Pharmaceuticals, Burlingame, CA), supplement of 
Rapamycin (3 mg/kg via portal vein, MilliporeSigma, 
Burlington, MA) or 3-Methyladenine (3-MA) (100 
μg/kg via portal vein, dissolved in DMSO, 
MilliporeSigma) at the time of liver graft procurement 
and immediately prior to reperfusion. Because all 
inhibitors (3-MA, CREB inhibitor and KLF4 inhibitor) 
were dissolved in DMSO, we added DMSO in PACAP 
solution for functional control. OLT survival was 
observed and the serum and OLT samples were 
collected at 6 h and 24 h post-transplant. 
Partial liver warm IRI model 
The artery and portal vein of cephalad lobes 
(70% of whole liver) were clamped by an atraumatic 
clip for 90 min [2,3,35-37]. A single dose of PACAP38 
(1 mg/kg i.v., dissolved in PBS) or CRP-CREB 
Interaction Inhibitor (CREB inhibitor: CAS92-78-4, 250 
μg/kg i.v., dissolved in DMSO, MilliporeSigma), or 
KLF4 inhibitor (Kenpaullone, 250 μg/kg i.v., 
dissolved in DMSO, MilliporeSigma [38]) was given 1 
h before warm ischemia. Ischemic liver tissue and 
serum samples were harvested at 6 h post 
reperfusion. All mice surgeries were approved by 
UCLA Animal Research Committee. 
Liver function and histology 
Serum alanine transaminase (sALT) indicated 
liver function was assessed by IDEXX Lab 
(Sacramento, CA). Hematoxylin and eosin-stained 
liver sections and electron microscopy imagine were 
analyzed blindly for liver histology. 
Quantitative RT-PCR 
Quantitative PCR was performed by using 
Platinum SYBR green quantitative PCR kit and 
QuantStudio3 Real-time PCR system (ThermoFisher). 
The used primer sequences were published [31-37] or 
shown in Table S1: LC3a, LC3b, Beclin-1, EGF, HGF, 
c-Met, KLF1, KLF2, KLF3 and KLF4. The ratios of 
target gene induction to housekeeping gene HPRT 
were calculated. 
Western blots 
Ischemic liver tissue proteins, after 
electrophoretic separation and transfer, were detected 
by monoclonal antibodies of Atg5 (12944), LC3 (4108), 
p62 (39749), proliferating cell nuclear antigen (PCNA) 
(13110), Ki67 (9129), pCREB (9198), KLF4 (12173), and 
β-actin (4970) (Cell Signaling Technology, Danvers, 
MA). 
H2O2 stressed hepatocytes assay 
After liver collagenase perfused digestion in situ, 
primary hepatocytes were separated by Percoll 
gradient centrifugation, and then cultured in 
collagen-coated plate for 24 h. Pre-treatment with 
PACAP38 (10 nM), with 3-MA (10 μM), CREB 
inhibitor (10 μM), KLF4 inhibitor (10 μM), DMSO for 1 
h, KLF4 siRNA or NC siRNA (transfected by 
Lipofectamine 2000, ThermoFisher), hepatocellular 
necrosis was triggered by hydrogen peroxide (H2O2: 
0.4 mM, MilliporeSigma). Cells were processed for 
immunofluorescence and PI staining after 6 h, 
whereas supernatants were assessed by ALT/LDH kit 
(ThermoFisher). 
Immunofluorescence staining 
Stressed hepatocytes were stained with LC3 
(4108), pCREB (9198) and KLF4 (12173) monoclonal 
antibodies (Cell Signaling Technology) followed with 
Alexa Fluor 488 secondary antibody (A11008), Alexa 
Fluor 555 F-actin conjugate (A34055) for cellular 
skeleton, and DAPI counterstain (P36931) 
(ThermoFisher). 
Propidium Iodide (PI) staining 
PI staining (ThermoFisher) was used to detect 
dead cells by binding DNA. Red fluorescence images 
were merged with bright-field images for blindly 
evaluation. 
Statistical analysis 
Liver graft survival curves were plotted by 
Kaplan-Meier survival analysis and Log-rank 
comparison test. All results were indicated by mean ± 
standard deviation, and analyzed with Student’s t test 
and ANOVA test. Statistical significant was identified 
as P<0.05. 
Results 
PACAP attenuates hepatic cold IRI and 
promotes OLT survival  
First, we studied whether administration of 
PACAP neuropeptide protected liver against 
extended cold storage-mediated IRI and prolonged 
graft survival in a mouse syngeneic OLT model. 
Compared with 41.7% survival in PBS control group, 
91.7% of recipients conditioned with PACAP 
remained alive at 14 days post-OLT (Figure 1A, 
p<0.001). As cold IR-exacerbated hepatocellular 
damage peaks at 6 h post-reperfusion [31-34], we then 
assessed OLT and sera samples at 6 h and 24 h. 
Similar as Rapamycin treated group (Figure S1, 
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autophagy agonist), PACAP treatment significantly 
diminished IRI-OLT, as shown by decreased sALT 
levels (Figure 1B, p<0.001) and preserved liver 
histology (without necrosis or congestion) (Figure 
1C). 
 
 
Figure 1. In syngeneic orthotopic liver transplantation subjected to extended cold storage (in 4°C UW solution for 20 h), there were three experimental groups (n = 12/group) 
of recipients treated with PBS, PACAP+DMSO or PACAP+3-MA at liver harvest and immediately prior to reperfusion through portal vein injection. (A) OLT survival rate was 
monitored during 14 days post-OLT: PBS (41.7%, red); PACAP+DMSO (91.7%, green, p<0.001); and PACAP+3-MA (50%, blue). Recipients were sacrificed at 6 h and 24 h 
post-transplant and OLT/serum samples were collected. (B) sALT levels; (C) liver pathology (H&E staining; magnification: x100: scale bar represents 200µm; x400: scale bar 
represents 20µm); (D) western blot of Atg5, LC3 I, LC3 II p62, PCNA, and Ki67; (E) qPCR-assisted detection of LC3a, LC3b, Beclin-1, EGF, HGF, and c-Met; (F) electron 
microscopy imagine of graft at 6 h post of OLT (red arrow indicated autophagosome, scale bar represents 0.5µm) (*p<0.001, n=4-6/group). 
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PACAP promotes hepatic autophagy 
PACAP therapy in IR-stressed livers enhanced 
hepatic autophagy induction, as assessed by 
expression of several key components (LC3, Beclin-1 
and Atg5), as compared with controls (Figure 1D-E, 
p<0.001). Consistently, PACAP neuropeptide 
augmented the expression level of LC3, diminished 
p62 level, as well as promoted the LC3 I to LC3 II 
conversion, which was identified as the critical active 
step in autophagy pathway (Figure 1D). Electron 
micrographs of autophagosome (red arrow) in liver 
graft at 6 h post of OLT were shown in Figure 1F. 
PACAP-mediated cytoprotection/ 
regeneration in OLT is autophagy-dependent 
We then determined the significance of PACAP- 
mediated hepatic autophagy in liver homeostasis by 
using an autophagy inhibitor 3-MA, which blocks the 
autophagosome formation in IR-stressed OLT. 
Autophagy inhibition diminished the induction of 
LC3 I, LC3 II and Beclin-1 (Figure 1D-E) and restored 
cardinal IRI-OLT features, i.e., increased sALT levels 
(Figure 1B) and deteriorated hepatic architecture 
(Figure 1C). Of note, PACAP monotherapy-mediated 
autophagy amplified downstream hepatocellular 
regeneration, i.e., PCNA, Ki67, epidermal growth 
factor (EGF), hepatocyte growth factor (HGF) and 
their receptor c-Met, as compared with controls 
(Figure 1D-E, p<0.001); whereas autophagy inhibition 
suspended hepatocyte repairing programs (PCNA, 
Ki67, EGF, HGF and c-Met) induced otherwise by 
PACAP-mediated autophagy (Figure 1D-E, p<0.001). 
PACAP-mediated autophagy prevents 
hepatocyte death 
We then analyzed neural modulation of PACAP- 
mediated autophagy in a well-controlled primary 
hepatocyte culture stimulated by hydrogen peroxide 
(H2O2), a system designed to mimic liver IRI in vivo. 
PACAP pre-treatment preferentially enhanced LC3 
induction and accumulation in hepatocellular nucleus 
and cytoplasm (Figure 2A: green fluorescence 
indicative of LC3), protected hepatocytes against 
oxidative stress (as shown by lower supernatant 
releasing of ALT/LDH (Figure 2C), and prevented 
hepatocyte death (Figure 2B: red fluorescence 
indicative of dead hepatocytes as PI cannot permeate 
live cells to stain nuclear chromosome). As 3-MA 
abolished LC3 accumulation in hepatocytes (Figure 
2A: no green fluorescence), autophagy inhibition 
exacerbated hepatocellular damage, evidenced by 
higher ALT/LDH (Figure 2C, p<0.001) and abundant 
PI positive hepatocytes (Figure 2B). 
PACAP-CREB axis is critical for hepatic 
autophagy in liver IRI 
As we have shown PACAP activated PKA- 
cAMP-CREB signaling in liver IRI [2,3], we 
consistently detected hepatic pCREB activation in 
cold-stored OLT (Figure 3A); and oxidative stressed 
hepatocyte cultures (Figure 3B: green fluorescence 
indicative of pCREB in hepatocellular nucleus/ 
cytoplasm). 
We then used a well-established murine model 
of partial liver warm ischemia (90 min) and 
reperfusion (6 h) to study the mechanism of PACAP- 
CREB axis-mediated autophagy in IR-damage. In 
agreement with our previous results [2,3], PACAP 
pre-treatment strongly depressed IR-mediated 
hepatocellular damage (Figure 3C-D); while CREB 
inhibition restored hepatic IR-damage, as shown by 
enhanced sALT levels and exacerbated IR-injured 
histology (Figure 3C-D). In parallel, CREB inhibition 
enhanced pro-inflammatory immune profile (Figure 
3E: TNF-α, IL-1β and CXCL-10, p<0.001) while 
reducing IL-10 level (Figure 3E, p<0.001). 
CREB is required for PACAP-mediated 
hepatic autophagy in liver IRI 
As PACAP promoted hepatic autophagy in liver 
IRI, PACAP administration failed to activate 
autophagy-related gene expression program after 
CREB inhibition in vivo (Figure 4A, p<0.001) and in 
oxidative stressed hepatocyte cultures (Figure 4C), 
implying that PACAP mediated hepatocellular 
autophagy was CREB-dependent. Furthermore, CREB 
inhibition abolished PACAP-mediated hepatocellular 
regeneration (Figure 4B), recreated oxidation- 
mediated hepacellular death and ALT/LDH release 
in hepatocytes in vitro (Figure 4D-E). 
PACAP-CREB signaling controls KLF4 in liver 
IRI 
Compared with controls, PACAP enhanced 
KLF4 gene induction (but not other KLFs (Figure S2)) 
and protein expression in both liver IRI (Figure 5A) 
and in vitro hepatocyte cultures (5B: green 
fluorescence indicative of KLF4 in hepatocellular 
nucleus/cytoplasm), which otherwise are diminished 
after CREB inhibition (Figure 5A-B). We then 
employed KLF4 inhibitor in liver warm IRI. In 
analogy with PACAP-CREB ablation, KLF4 inhibition 
blunted PACAP-mediated cytoprotection, and 
restored IR-induced hepatocellular injury, as shown 
by increased sALT levels (Figure 5C) and deteriorated 
liver pathology (Figure 5D). In addition, KLF4 
inhibition recreated PACAP-suspended pro- 
inflammatory cytokine program (Figure 5E: TNF-α, 
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IL-1β, CXCL-10, p<0.001), and suppressed IL-10 
expression (Figure 5E, p<0.001). 
KLF4 is essential for PACAP-CREB-mediated 
hepatic autophagy in liver IRI 
KLF4 suspension significantly diminished 
otherwise abundant hepatic autophagy related 
components (Figure 6A) and hepatocellular 
regeneration programs (Figure 6B) in PACAP- 
conditioned liver IRI. Consistently, KLF4 inhibition 
attenuated PACAP-mediated hepatocellular 
autophagy in stressed hepatocyte cultures (Figure 
6C), and restored hepatocyte damage, as shown by 
amplified cell death and ALT/LDH release (Figure 
6D-E and Figure S3). 
 
 
Figure 2. PACAP-mediated hepatocellular autophagy in vitro. Primary hepatocytes were pre-treated with PACAP+DMSO, or PACAP+3-MA 1 h prior to H2O2 stress. (A) 
Representative immunofluorescence staining: LC3 (green), cellular skeleton (F-actin, red) and nuclear (DAPI, blue): LC3 accumulation in cytoplasm and nucleus (magnification: 
x400, scale bar represents 20µm); (B) PI staining: red fluorescence images (PI stained nuclear of dead cells) were merged with brightfield images: live cells (blue arrows) and dead 
cells (red arrows) (magnification: x200, scale bar represents 50µm); (C) supernatant ALT/LDH levels (*p<0.001, n=6/group). 
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Figure 3. PACAP-CREB axis in liver IRI. (A) Western blot of pCREB in cold storage stressed OLT; (B) representative immunofluorescence staining of pCREB (green), F-actin 
(red) and DAPI (blue): pCREB accumulation in nuclear (magnification: x400, scale bar represents 20µm). PACAP+DMSO, PACAP+CREB inhibitor or PBS pre-treated WT mice 
were subjected to partial liver warm ischemia (90 min). Ischemic liver tissues were harvested at 6 h of reperfusion for (C) sALT levels; (D) liver pathology (H&E staining; 
magnification: x100: scale bar represents 200µm; x400: scale bar represents 20µm); (E) qPCR of TNF-α, IL-1β, CXCL-10 and IL-10 (*p<0.001, n=4-6/group).  
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Figure 4. CREB activation is essential in PACAP-mediated hepatic autophagy in liver IRI. PACAP+DMSO, PACAP+CREB inhibitor or PBS pre-treated WT mice were subjected 
to partial liver warm ischemia (90 min). Ischemic liver tissues were harvested at 6 h of reperfusion for (A) western blot of Atg5, LC3 I and LC3 II; (B) qPCR-assisted detection 
of LC3a, LC3b, Beclin-1, EGF, HGF, and c-Met (n=4-6/group, *p<0.001). (C) Immunofluorescence staining: LC3 (green), F-actin (red) and DAPI (blue): LC3 accumulation in 
cytoplasm and nuclear (magnification: x400, scale bar represents 20µm); (D) PI staining (red): live cells (blue arrows) and dead cells (red arrows) (magnification: x200, scale bar 
represents 50µm); (E) supernatant ALT and LDH levels (*p<0.001, n=6/group). 
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Figure 5. KLF4 in PACAP-CREB axis controls hepatocellular function in liver IRI. (A) qPCR and western blot of KLF4 in ischemic livers (*p<0.001); (B) Representative 
immunofluorescence staining of KLF4 (green) and F-actin (red): nuclear KLF4 accumulation (magnification: x400, scale bar represents 20µm). PACAP+DMSO, PACAP+KLF4 
inhibitor or PBS pre-treated WT mice were subjected to partial liver warm ischemia (90 min). Ischemic liver tissues were harvested at 6 h of reperfusion for (C) sALT levels; (D) 
liver histology (representative H&E staining; magnification: x100: scale bar represents 200µm; x400: scale bar represents 20μm); (E) qPCR-assisted detection of TNF-α, IL-1β, 
CXCL-10 and IL-10 (*p<0.001, n=4-6/group). 
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Figure 6. KLF4 is critical in PACAP-CREB axis-mediated hepatic autophagy in liver IRI. PACAP+DMSO, PACAP+KLF4 inhibitor or PBS pre-treated WT mice were subjected 
to 90 min ischemia. Liver samples were analyzed at 6 h of reperfusion for (A) western blot-assisted detection of Atg5, LC3 I and LC3 II; (B) qPCR-assisted detection of LC3a, 
LC3b, Beclin-1, EGF, HGF, and c-Met (n=4-6/group, *p<0.001). (C) Immunofluorescence staining: LC3 (green), F-actin (red) and DAPI (blue): LC3 accumulation in cytoplasm and 
nucleus (magnification: x400, scale bar represents 20µm); (D) PI staining (red): live cells (blue arrows) and dead cells (red arrows) (magnification: x200, scale bar represents 
50µm); (E) supernatant ALT and LDH levels (*p<0.001, n=6/group). 
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Discussion 
In a murine model of warm IRI, we have 
previously shown that treatment with PACAP 
neuropeptide controlled innate immunity-mediated 
macrophage function and modulated hepatic 
homeostasis [2,3]. In the present study: (i) exogenous 
PACAP neuropeptide promoted liver graft survival in 
a mouse model of extended cold storage followed by 
OLT, which mimics the clinical scenario; (ii) PACAP- 
enhanced autophagy was essential for hepatic 
cytoprotection in IR-stressed OLT; (iii) PACAP- 
mediated hepatocellular regeneration in liver IRI was 
autophagy-dependent; and (iv) CREB-KLF4 axis was 
critical in PACAP-modulated liver autophagy and 
regaining homeostasis in IRI-OLT. 
In a warm hepatic IRI model, PACAP treatment 
diminished macrophage inflammation response in 
PKA-dependent manner and prevented 
hepatocellular necrosis/apoptosis through YAP 
signaling [2,3]. Others reported that PACAP induced 
DSCR1 [39], which mediated mitochondrial 
autophagy in neurons [40]. In our current cold 
ischemia-mediated OLT injury model, administration 
of PACAP neuropeptide ameliorated liver IRI by 
promoting autophagy program, i.e., hepatic 
expression of Atg5, LC3, Beclin-1 and transformation 
of LC3 I to LC3 II, the key elements for 
autophagosome formation; while enhancing the 
regenerative gene program (EGF, HGF, and c-Met), as 
compared with IRI-OLT controls. 3-MA inhibited 
autophagy by inhibition of class III 
Phosphatidylinositol 3-kinases (PI-3K), which is the 
activator of upstream of autophagy and CREB 
respectively [41]. In contrast, administration of 
autophagy inhibitor 3-MA exacerbated hepatic IRI, 
abolished autophagy activation/liver regeneration, 
suggesting PACAP-mediated cytoprotection/ 
hemostasis in cold IRI-OLT was an autophagy- 
dependent phenomenon. Inhibitors may have some 
limitations, i.e. multiple molecular targets, short life 
span and increasing the risk of toxicity. Indeed, we 
examined the hepatocellular autophagy in PACAP 
KO mice in a mouse model of extended cold storage 
followed by OLT. As the liver graft damage was 
exacerbated at 6 h post OLT, the hepatic autophagy 
was abolished in OLTs (data not shown). 
To mimic liver IR-mediated hepatocellular 
hyperoxidation insult in vivo, we then analyzed 
PACAP modulation in a well-controlled hydrogen 
peroxide (H2O2) stimulated primary hepatocyte 
cultures. To further determine whether PACAP- 
exerted cytoprotection was autophagy-dependent, we 
first monitored the autophagy activity in PACAP 
treated primary hepatocytes by immunofluorescence 
staining. Markedly increased LC3 accumulation was 
found in hepatocellular nucleus and cytoplasm of 
PACAP-treated hepatocytes. Hyperoxidative 
hepatocellular necrosis is typically featured as loss of 
cell membrane integrity and releasing of cellular 
enzymes. As PI dye is unable to permeate through the 
intact cell membrane of live cells, PI stains dead cell 
DNA as diffusion into the porous membrane. 
Interestingly, PACAP prevented oxidation stressed 
hepatocellular death, while control group exhibited 
notable PI-indicated dead cells and hepatocellular 
release of ALT/LDH in supernatants. Consistently, 
autophagy inhibition eliminated LC3 accumulation in 
PACAP-treated hepatocytes, and recreated 
hyperoxidative cell death, evidenced by massive PI 
staining and elevated ALT/LDH levels. 
Activation of CREB signaling preferentially 
promoted autophagy-mediated neuroprotection in a 
rat model of Alzheimer’s disease [41]. As the newly 
identified transcriptional activator of autophagy, 
CREB promoted lipophagy (autophagic degradation 
of intracellular lipid droplets) and activated total 112 
autophagy related genes during nutrient deprivation 
[22,42]. As previously discovered that PACAP- 
triggered PKA-CREB axis and CREB-YAP signaling in 
liver IRI [2,3,43,44], we then evaluated CREB 
phosphorylation in PACAP-enhanced hepatic 
autophagy. Having shown that PACAP neuropeptide 
significantly improved CREB activation, we next 
employed a CREB inhibitor to analyze PACAP- 
mediated modulation in IR-stressed liver. Strikingly, 
CREB antagonism not only potentiated hepatic pro- 
inflammation response in otherwise PACAP treated 
and IR-resistant hosts, but also recreated liver IR- 
damage. In parallel, both autophagy and 
regeneration-related gene expression programs, 
promoted by PACAP stimulation, were abolished by 
CREB inhibitor. Meanwhile, CREB inhibition 
impaired hepatocellular LC3 abundance in PACAP- 
promoted autophagy, and restored cellular death in 
oxidation-stressed hepatocyte culture. These findings 
support the contention that PACAP mediated PKA- 
CREB pathway is critical for hepatic autophagic 
cytoprotection in liver IRI. 
KLF4, a pleiotropic transcription factor, 
regulates cellular differentiation, proliferation and 
oncogenesis [45,46]. KLF4-mediated cell 
reprogramming contributed to tissue homeostasis in 
IR-damaged heart, brain and kidney [47-49], while 
KLF4 deficiency diminished autophagy in embryonic 
fibroblasts [50]. It has been reported that CREB 
coactivated KLF4 transcription via histone acetylation 
[51]. In fact, we observed PACAP neuropeptide 
promoted hepatic KLF4 expression in liver IRI, while 
CREB inhibitor abolished PACAP-mediated 
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stimulation and eliminated KLF4 expression in 
primary hepatocytes. As KLF4 synergized with CREB 
in atherosclerosis and co-regulated the renal 
progenitor cell proliferation with PACAP [52], we 
then asked whether KLF4 contributed to the 
regulation of PACAP-CREB axis in our model. 
Indeed, KLF4 inhibition amplified macrophage innate 
immune activation, and impaired PACAP-CREB 
mediated autophagic cytoprotection. Further, KLF4 
inhibitor abolished otherwise abundant LC3/Beclin-1 
expression in PACAP-treated IR-stressed livers and 
oxidation-stressed primary hepatocytes, confirming 
the integrality of PACAP-CREB-KLF4 was 
indispensable in autophagy-mediated cytoprotection 
in liver IRI. 
In conclusion, this study documented PACAP 
attenuated liver IR-injury and prolonged graft 
survival in a clinically relevant cold IR stressed OLT 
model. Exogenous PACAP neuropeptide-enhanced 
autophagy controls hepatic cytoprotection, while 
proficient PACAP-CREB-KLF4 signaling is essential 
for regaining hepatocellular homeostasis. Consistent 
with the emerging function of autophagy-mediated 
cytoprotection against IR-stress [53], this study 
supports PACAP neuropeptide as a novel treatment 
in liver transplantation. 
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